everyone at greylock valued making products. it is characteristic of david to enter the question like, no, it was everybody else. emily: you did find facebook and linkedin. you convinced reid hoffman to join the firm. how did you do that? how do you do that? john: again, it comes down to -- we believe if you come from product and you have that background and network, there is an authenticity. most people do not remember this, but in 2005, when facebook took the investment the valuation was $500 million. which seemed, to most people -- emily: there were just students on it at the time. john: right, and not that many. it seemed like an insane valuation. i think many people looked at that and said, dave sze and greylock have lost their minds. not just from the outside. partners from the inside said this is insane, not what we do. emily: who said that? david: we had partners. one of the characteristics of our partnership is we like to disagree. we like to push each other. there were partners saying, this will ruin the firm. this is

joining me today on this edition of "studio 1.0," greylock partners david sze and john lilly.have been at the firm for 15 years?

emily: stern that plays an advisory role at greylock capital.ind a full interview on bloomberg.com. coming up, the key dividing the world's most -- the key to fighting the world's most drug resistant bacteria could be out in nature. the bioresearch happening deep underground. ♪ emily: the rise of drug-resistant bacteria created a need for new biotics. the answer might be in nature. we followed one microbiologist searching in the most unlikely place for the key to fighting super bugs. >> there is a quiet crisis going on in hospitals around the world right now. certain strains of bacteria no longer respond to any known antibiotics. there is a word for these antibiotic resistant deck area -- we call them super bugs. unless we can develop new antibiotics, super bugs could make a lot of people very very sick. >> we are racing against the clock. you already see a number of people who have died a meaningless death because they had these minor infections. us to lookative for into new drugs and new sources of what could be the habitat for new drugs. ♪ th